Snake venom phospholipases A2: a new class of antitumor agents.
Phospholipases A(2) (PLA(2)) are enzymes of high medical scientific interest due to their involvement in a large number of human inflammatory diseases. PLA(2) constitute a diverse family of enzymes which catalyses the hydrolysis of the sn-2 ester bond in glycerophospholipids and exhibit a wide range of physiological and pathological effects. The ubiquitous nature of PLA(2) highlights the important role they play in many biological processes, as cell signaling and cell growth, including the generation of proinflammatory lipid mediators such as prostaglandin and leukotrienes, regulation of lipid mediators. The activity and expression of several PLA(2) isoforms are increased in several human cancers, suggesting that these enzymes have a central role in both tumor development and progression and can be targets for anti-cancer drugs. On the other hand, some PLA(2) isolated from Viperidae venoms are capable to induce antitumoral activity. In summary PLA(2) from snake venoms can be a new class of anticancer agents and provide new molecular and biological insights of cancer development.
Rodrigues
Renata S
RS
Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia-Uberlândia-MG, Brazil.
Izidoro
Luiz Fernando M
LF
de Oliveira
Robson J
RJ
Sampaio
Suely V
SV
Soares
Andreimar M
AM
Rodrigues
Veridiana M
VM
D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D054467:Phospholipases A2 / Q000378:metabolism / Q000627:therapeutic use*; D012910:Snake Venoms / Q000201:enzymology* / Q000627:therapeutic use; D012911:Snakes
D000970:Antineoplastic Agents; D012910:Snake Venoms; D054467:Phospholipases A2